Navigation Links
Case Western Reserve University receives $1.66m grant from NIH for otoprotection research

CLEVELAND April 13, 2009 Qing Yin Zheng, M.D., assistant professor of Otolaryngology-Head and Neck Surgery and Genetics at the Case Western Reserve University School of Medicine, and member of the Case Comprehensive Cancer Center, has been awarded a five year $1.66 million grant from the National Institutes of Health (NIH) Research Project Grant Program (R01) to explore the impact of several molecular pathways on inner ear dysfunction in Ushers syndrome.

Usher Syndrome (USH) is a clinically and genetically heterogeneous disorder characterized by congenital deafness and retinitis pigmentosa. It is the most common cause of deafness accompanied by blindness. *There are about 10-15,000 people with Usher syndrome in the United States today and it accounts for 6 percent of the congenitally deaf population and more than 50 percent of the deaf- blind population. While there is currently no medical treatment for Usher syndrome, cochlear implants have been found to be very affective in patients with severe or profound hearing loss.

"Many USH patients benefit from cochlear implants, but preservation and a minimal density of spiral ganglion cells are required for an effective implant," said Zheng.

Spiral ganglion cells are the cells that provide the sense of hearing by sending sound waves from the cochlea to the brain. Dr. Zheng believes residual hair cells in the cochlea could promote the survival of the spiral ganglion neurons by release of neurotrophic substances or growth factors, and as a result he is particularly interested in the discovery of therapeutic targets that prevent hair cell death, as this is the key to helping Usher 1 patients to respond to cochlear implants and other treatment options successfully.

"Hair cell replacement or regeneration therapies have not really solved the deafness problem of ear diseases," said Zheng. "An alternative to replacing lost hair cells is to prevent their loss in the first place."

This grant is Dr. Zheng's fourth NIH grant for research involving auditory disease with accumulated $4 million funding.

"A clear translational goal, expertise of his research team and a very strong publication record, Dr. Zheng has potential to uncover new therapeutic approaches to treat hearing loss in Usher syndrome. I'm very grateful for the NIH for its forward-thinking commitment to Dr. Zheng and his innovative medical science research," said Dr. James Arnold, Julius McCall Professor and Chair of the Department of Otolaryngology Head and Neck Surgery at Case Western Reserve University School of Medicine.

Dr. Zheng aims to: 1) identify the mutation in and characterize a new mouse deafness model (for Usher 1 syndrome and presbycusis or age-related hearing loss) that provides an ideal window of time for evaluating drug therapy; 2) identify key molecules and mechanisms that lead to hair cell death and hearing loss in the models for the Usher 1 syndrome; 3) prove the concept that genetic hearing loss and hair cell death can be prevented by otoprotection therapy.

"We are very honored and pleased that our department has been given this significant award from the NIH," says Dr. Cliff Megerian, Richard W. and Patricia Pogue Professor of Auditory Surgery and Hearing Sciences at University Hospitals Case Medical Center. "The impact of deafness on quality of life and language development is devastating. The financial impact and individual human suffering are devastating, due to the lack of effective drug therapy," adds Dr. Megerian who has collaborated on several research projects with Dr. Zheng.


Contact: Christina DeAngelis
Case Western Reserve University

Related biology news :

1. The fragility of the worlds coral is revealed through a study of the Northwestern Hawaiian Islands
2. Collaboration leads to success: Most powerful computer of its kind in western N.Y. available worldwide
3. Diabetics on high-fiber diets might need extra calcium, report UT Southwestern researchers
4. Two UT Southwestern researchers awarded Sloan fellowships
5. Antioxidants in Midwestern black raspberries influenced by production site
6. UT Southwestern researchers identify molecule that helps the sleep-deprived to mentally rebound
7. Case Western Reserve researchers develop wireless activation of brain circuits
8. Case Western Reserve researchers looking at light-induced toxins in air and water
9. UT Southwestern researchers disrupt biochemical system involved in cancer, degenerative disease
10. Natural brain substance blocks weight gain in mice, UT Southwestern researchers discover
11. Climate changes impact on invasive plants in Western US may create restoration opportunities
Post Your Comments:
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: ... banks to provide their customers enhanced security to ...
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... NEWPORT BEACH, Calif. , June 23, 2016 /PRNewswire/ ... offering new biological discoveries to the medical community, has ... and co-founder Matthew Nunez . "We ... provide us with the capital we need to meet ... funding will essentially provide us the runway to complete ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free validated ... will showcase its product’s latest features from June 26 to June 30, 2016 ... on Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug ...
(Date:6/23/2016)... June 22, 2016  Amgen (NASDAQ: AMGN ... QB3@953 life sciences incubator to accelerate the ... shared laboratory space at QB3@953 was created to help ... obstacle for many early stage organizations - access to ... sponsorship, Amgen launched two "Amgen Golden Ticket" awards, providing ...
Breaking Biology Technology: